Bill Text: CA AB1619 | 2023-2024 | Regular Session | Amended

---

Bill Title: Pharmacists: drug disclosures: cannabis or cannabidiol interactions.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2024-02-01 - From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. [AB1619 Detail]

Download: California-2023-AB1619-Amended.html

---

Amended  IN  Assembly  March 23, 2023

CALIFORNIA LEGISLATURE— 2023–2024 REGULAR SESSION

Assembly Bill

No. 1619

---

Introduced by Assembly Member Dixon

February 17, 2023

---

An act to add Section 4074.1 to the Business and Professions Code, relating to pharmacy.

LEGISLATIVE COUNSEL'S DIGEST

AB 1619, as amended, Dixon. Pharmacists: drug disclosures: cannabis or cannabidiol interactions.

The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires a pharmacist to inform a patient orally or in writing of the harmful effects of a drug dispensed by prescription if a prescription drug poses a substantial risk to the person consuming the drug when taken in combination with alcohol or if the drug may impair a person’s ability to drive a motor vehicle, and the board has determined that the drug is a drug or drug type for which this warning shall be given. A violation of the Pharmacy Law is a crime.

This bill would require a pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products to display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information. The bill would require a pharmacy to develop a cannabis labeling guideline on which medications require a label pursuant to the bill. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

Digest Key

Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: YES  

---

Bill Text

The people of the State of California do enact as follows:

SECTION 1.

 Section 4074.1 is added to the Business and Professions Code, to read:

4074.1.

 (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.

(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).

SEC. 2.

 No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIII B of the California Constitution.